SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended			3 Months Ended				3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2014 Stock Options	Mar. 31, 2013 Stock Options	Mar. 31, 2014 Equity Appreciation Rights Plan	Mar. 31, 2013 Equity Appreciation Rights Plan	Mar. 31, 2014 2010 Plan Equity Appreciation Rights Plan	Mar. 31, 2013 2010 Plan Equity Appreciation Rights Plan	Nov. 30, 2010 2010 Plan Equity Appreciation Rights Plan Maximum
Shares
Balance at the beginning of the period(in shares)				216,000
Granted (in shares)				0
Cancelled (in shares)				0
Balance at the end of the period (in shares)				216,000
Exercisable at the end of the period (in shares)				192,918
Weighted-Average Exercise Price Per Share
Outstanding at the beginning of the period (in dollars per share)				$ 6.46
Granted (in dollars per share)				$ 0.00
Cancelled (in dollars per share)				$ 0.00
Outstanding at the end of the period (in dollars per share)				$ 6.46
Exercisable at the end of the period (in dollars per share)				$ 6.77
Weighted-Average Remaining Contractual Term
Outstanding at the end of the period				3 years 3 months 29 days
Exercisable at the end of the period				2 years 7 months 24 days
Aggregate Intrinsic Value
Outstanding at the end of the period				$ 48,953
Exercisable at the end of the period				16,320
Additional disclosures
Stock options exercised				0	0
Weighted-average fair value of options granted (in dollars per share)					$ 1.65
Compensation expense				7,482	3,781			43,000	14,000
Unrecognized compensation related to unvested awards				39,000
Weighted-average period over which unrecognized compensation costs expected to be recognized				1 year 8 months 5 days
Equity Appreciation Rights Plan
Number of common shares authorized										750,000
Vesting period from the base date								3 years
Redemption cash payment period								90 days
Shares granted (in units)								750,000
Shares outstanding (in units)						650,000
Accrued compensation						124,000	81,000
Accrued compensation included in Other Accrued Liabilities	35,000		29,000
Accrued compensation included in Other Long-Term Liabilities	$ 89,000		$ 52,000
Earnings Per Common Share:
Options outstanding included in computation of per-share amounts (in shares)	26,750	0
Outstanding options included computation of dilutive per-share amounts as effect of all outstanding stock-based awards were antidilutive	189,250